Cyanotech (CYAN)
OTHER OTC:CYAN
CYAN Stock Chart & Stats
$0.35
$0.00(0.00%)
At close: 4:00 PM EST
$0.35
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$0.21 - $0.57
Previous CloseN/A
VolumeN/A
Average Volume (3M)6.46K
Market Cap
$2.22M
Enterprise Value$13.54M
Total Cash (Recent Filing)$649.00K
Total Debt (Recent Filing)$15.07M
Price to Earnings (P/E)―
Beta0.02
Next Earnings
Jun 30, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.03
Shares Outstanding7,392,243
10 Day Avg. Volume1,585
30 Day Avg. Volume6,463
Financial Highlights & Ratios
PEG Ratio0.02
Price to Book (P/B)0.28
Price to Sales (P/S)0.10
P/FCF Ratio-1.72
Enterprise Value/Market Cap6.11
Enterprise Value/Revenue0.54
Enterprise Value/Gross Profit1.67
Enterprise Value/Ebitda14.88
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Vertically Integrated Microalgae ProductionOwning cultivation and processing gives Cyanotech durable control over raw material quality, yields and costs. Vertical integration creates barriers for new entrants, supports product traceability for natural ingredient buyers, and enables long-term margin and supply reliability improvements.
Two Revenue Streams: Branded Goods And Bulk IngredientsA dual-channel model (branded finished goods plus bulk B2B ingredients) provides structural diversification. It lets management shift mix toward higher-margin branded items or stable ingredient contracts, smoothing revenue volatility and supporting sustainable margin expansion over time.
Commercial Manufacturing PartnershipThe Zivo manufacturing agreement represents a structural commercial win: it leverages Cyanotech's production capacity, validates technical capabilities, and can create contracted revenue, improved utilization, and new market entry into animal health and functional nutrition over the medium term.
Bears Say
Ongoing UnprofitabilitySustained negative margins indicate the business has not reached operational profitability. Losses erode retained capital, limit internal reinvestment in cultivation capacity or marketing, and mean improvement must be structural rather than cyclical to restore long-term viability.
High Financial LeverageA debt-to-equity ratio near 1.5 imposes ongoing interest and principal obligations that reduce financial flexibility. High leverage magnifies risk from operational swings in a commodity-linked business and can constrain capex, R&D and strategic investments over multiple quarters.
Weak Cash GenerationNegative operating cash flow and a marked decline in free cash flow signal persistent cash burn. Poor cash generation limits the firm's ability to fund maintenance of production assets, support growth or service debt without external financing, creating a structural liquidity vulnerability.
Cyanotech News
CYAN FAQ
What was Cyanotech’s price range in the past 12 months?
Cyanotech lowest stock price was $0.21 and its highest was $0.57 in the past 12 months.
What is Cyanotech’s market cap?
Cyanotech’s market cap is $2.22M.
When is Cyanotech’s upcoming earnings report date?
Cyanotech’s upcoming earnings report date is Jun 30, 2026 which is in 81 days.
How were Cyanotech’s earnings last quarter?
Currently, no data Available
Is Cyanotech overvalued?
According to Wall Street analysts Cyanotech’s price is currently Overvalued.
Does Cyanotech pay dividends?
Cyanotech does not currently pay dividends.
What is Cyanotech’s EPS estimate?
Cyanotech’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Cyanotech have?
Cyanotech has 7,392,243 shares outstanding.
What happened to Cyanotech’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Cyanotech?
Currently, no hedge funds are holding shares in CYAN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Cyanotech
Cyanotech Corporation (CYAN) is a biotechnology company based in Hawaii that specializes in the cultivation and processing of microalgae. Operating primarily in the nutritional supplements and specialty chemical sectors, Cyanotech produces high-quality products such as Astaxanthin, a powerful antioxidant derived from the microalgae Haematococcus pluvialis, and Spirulina, a nutrient-rich blue-green algae. The company's core offerings are focused on health and wellness, catering to consumers seeking natural dietary supplements and functional foods.
Technical Analysis
Nature's Sunshine Products
―
Seneca Foods
―
Hain Celestial
―
USANA Health
―
Laird Superfood
―
Ownership Overview
Options Prices
Currently, No data available
---